The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2017 | Getting specific with myeloma therapy: selecting the right treatments
Saad Usmani
• 24 Jun 2017
There are so many new and existing agents, regimes, combinations to and mechanisms to consider when treating myeloma patients. Dr Saad Z Usmani, Carolinas Healthcare System, Charlotte, NC, tells us what’s happening within the clinical research community to tackle these challenges during the European Society of Hematology meeting in Madrid.
